Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic Treatment NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) — Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY) a…
Tilray Medical is a leading provider of EU-GMP certified and pharmaceutical-grade medical cannabis products, having supplied over 20 countries with a comprehensive portfolio of THC and CBD products. …